The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer
Clinical trial NCT02487992 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02487992
- Sponsor
- The First People's Hospital of Changzhou
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2043-07-01
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.